Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

Carcinogenesis - 1 Sept 2003

Rylander-Rudqvist Tove, Wedren Sara, Granath Fredrik, Humphreys Keith, Ahlberg Susanne, Weiderpass Elisabete, Oscarson Mikael, Ingelman-Sundberg Magnus, Persson Ingemar

Abstract excerpt

Cytochrome P450 1B1 (CYP1B1) is active in the metabolism of estrogens to reactive catechols and of different procarcinogens. Several studies have investigated the relationship between genetic polymorphisms of CYP1B1 and breast cancer risk, however, with inconsistent results. We investigated such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP1B1

Share to Estrogen Replacement Therapy

Share to Haplotypes

Share to Menopause

Source

Identifiers

PMID: 12844487
DOI: 10.1093/carcin/bgg114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12844487-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.PMID 12844487Read ↗

Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.Semantic proximity Read ↗

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.Semantic proximity Read ↗

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.Semantic proximity Read ↗

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.Semantic proximity Read ↗

Association of CYP1B1 polymorphisms and breast cancer risk.Semantic proximity Read ↗

Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.Semantic proximity Read ↗

Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.Semantic proximity Read ↗

CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer.Semantic proximity Read ↗

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.Semantic proximity Read ↗

Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.Semantic proximity Read ↗

CYP17 and breast cancer: no overall effect, but what about interactions?Semantic proximity Read ↗

Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.